1. Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease. (November 2017) Authors: Sun, Haoping; Olsen, Henrik S.; Mérigeon, Emmanuel Y.; So, Edward; Burch, Erin; Kinsey, Susan; Papadimitriou, John C.; Drachenberg, Cinthia B.; Bentzen, Søren M.; Block, David S.; Strome, Scott E.; Zhang, Xiaoyu Journal: Journal of autoimmunity Issue: Volume 84(2017) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗